---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-003631"
form_type: "8-K"
ticker: "PAVM"
cik: "0001624326"
company_name: "PAVmed Inc."
filed_at: "2025-01-24T23:59:59+00:00"
generated_at: "2026-05-27T11:14:03.564957+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# PAVmed receives Nasdaq minimum bid price deficiency notice; sells Series C preferred shares

## Summary
- Nasdaq notice on Jan 23: common stock closing bid below $1 for 30 consecutive days; 180-day cure period until July 22, 2025.
- To regain compliance, closing bid must be at least $1 for 10 consecutive business days.
- On Jan 24, sold 2,653 Series C Convertible Preferred shares for ~$2.653M via cancellation of unsecured debt.
- Conversion at voluntary price $1.068/share would issue ~2.48M common shares; at floor $0.2136, ~12.42M shares.
- Company intends to consider all available options to regain compliance with Nasdaq listing standards.

## SEC filing metadata
- accession: 0001493152-25-003631
- form_type: 8-K
- ticker: PAVM
- cik: 0001624326
- company_name: PAVmed Inc.
- filed_at: 2025-01-24T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 3.02, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1624326/000149315225003631/0001493152-25-003631-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1624326/000149315225003631/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-003631
- JSON: https://secwatch.observer/filing/0001493152-25-003631.json
- Plain text: https://secwatch.observer/filing/0001493152-25-003631.txt

## Source-grounded claims
- claim_id: 01fa7671be6516dc25ef0ab30cc14bd838069216
  claim: PAVmed Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  evidence_excerpt: January 23, 2025, PAVmed Inc. (the “ Company ”) received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) stating that, for the prior 30 consecutive business days (through J
  evidence_url: https://www.sec.gov/Archives/edgar/data/1624326/000149315225003631/0001493152-25-003631-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.